| Literature DB >> 23901269 |
Kui Liu1, Xialu Lin, Jinshun Zhao.
Abstract
Due to their chemical stability and nonallergic, nonirritant, and ultraviolet protective properties, titanium dioxide (TiO2) nanoparticles (NPs) have been widely used in industries such as electronics, optics, and material sciences, as well as architecture, medicine, and pharmacology. However, increasing concerns have been raised in regards to its ecotoxicity and toxicity on the aquatic environment as well as to humans. Although insights have been gained into the effects of TiO2 NPs on susceptible biological systems, there is still much ground to be covered, particularly in respect of our knowledge of the effects of the interaction of TiO2 NPs with other chemicals or physical factors. Studies suggest that interactions of TiO2 NPs with other chemicals or physical factors may result in an increase in toxicity or adverse effects. This review highlights recent progress in the study of the interactive effects of TiO2 NPs with other chemicals or physical factors.Entities:
Keywords: TiO2; chemicals; interaction; nanoparticles; physical factors; titanium dioxide
Mesh:
Substances:
Year: 2013 PMID: 23901269 PMCID: PMC3720578 DOI: 10.2147/IJN.S46919
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Toxicokinetics and accumulation sites of titanium dioxide nanoparticles.
Note: Reprinted from Shi et al,13 Copyright 2013, with permission from BioMed Central Publishing.
Abbreviation: GI, gastrointestinal.
Studies in vitro on the interactive effects of TiO2 NPs with chemicals or physical factors
| Reference | Supplier | Characteristics of TiO2NP
| Dispersion method | Exposure concentration (μg/mL) | Exposure time | Cell line | Culture medium | Combined factors/exposure condition | Combined effects | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Particle size (nm) | Crystal structure | Surface area (m2/g) | |||||||||
| 23 | Degussa | 21 | 80% anatase, 20% rutile | 49.6 | 10 min ultrasonication and 30 s vortex mixing | 0.001, 0.01, 0.1, 1, 10 | 24 h | L-02 | DMEM | PbAC/1 μg/mL | Cell viability↓, ROS↑, GSH↑, SOD↓, 8-OHdG↑, OGG1 expression↑ |
| 40 | Degussa | 25 | 80% anatase, 20% rutile | 50 | Suspended fresh immediately before use | 0, 0.25, 0.5, 0.75, 1, 1.25 TU (1TU = 10.05 μg/mL) | 24 h | HEK293T | DMEM | CdCl2/0, 0.25, 0.5, 0.75, 1, 1.25 TU (1 TU = 5.12 μmol/L) | |
| 49 | Degussa | 25–50 | 80% anatase, 20% rutile | 50 | vortexed for 2 min, ultrasonicated for 10 min | 0, 1, 5, 10 | 24 h | L-02 | DMEM | BPA/0, 0.1, 1, 10μmol/L | Cell viability↔, ROS↑, MDA↑, DNA double strand break↑, chromosomal damage↑ |
| 55 | Degussa | 25 | 80% anatase, 20% rutile | 50 | NA | 0, 0.01, 0.1, 1 | 12, 24, 36 h | L-02 | DMEM | p,p′-DDT/0, 0.001, 0.01, and 0.1 μmol/L | Cell viability↔, apoptosis test↔, ROS↑, MDA↑, 8-OHdG↑; DNA strand break↑; micronucleus frequency↑ |
| 57 | Degussa | 21 | 80% anatase, 20% rutile | NA | Ultrasonicated for 40 min | 0, 10 | 72 h | 16-HBE | RPMI-1640 | NaF/0, 10, 20, 30 mg/L | Cell viability↔, apoptosis test↑, SOD↓, MDA↑, NO↑ |
| 65 | Degussa | 20 | rutile and anatase | 50 | Ultrasonicated for 15 min | 50 | 1 h | HaCaT | NA | Nitrite, UVA/nitrite: 0, 0.1, 0.5, 1, 2 mM; UVA: 365 nm, 0.6 mW/cm2, 1 h | Cell viability↓, apoptosis test↑, protein tyrosine nitration↑ |
| 66 | Wanjin Material Corp; Degussa | 4, 10, 21 25, or 60 | anatase, rutile; anatase/rutile (3:1) | NA | Freshly prepared and diluted | 0, 10, 50, 100, 200 | 1 h | HaCaT | MEM | UVA/365 nm, 3.5 mW/cm2, 1 h | Cell viability↓, SOD↓, ROS↑, MDA↑ |
| 67 | Degussa | 20 | 70%–85% anatase and 30%–15% rutile | 48.08 | Sonicated for 30 min | 0, 1, 5 | 0, 24, 48 h | Human peripheral blood lymphocytes | RPMI-1640 | UVA/365 nm, 2.0 mW/cm2, 0, 24, 48 h | Cell viability↓, sub-G1 phase↑, caspase-9↑, caspase-3↑, and PARP↑ MMP↓, ROS↑DNA damage↑micronucleus formation↑ |
| 68 | Sigma Chemicals Degussa | <25, <100; 31 | anatase, rutile; 86% anatase, 14% rutile | NA | Sonicated for 30 min | 50, 100 | 4 h | HaCaT | DMEM | UvA/320–390 nm; 0, 2.5, 5.0, and 10 J/cm2 | MTS assay (A325, P25 and A25)↓, ROS↑ |
| 71 | Degussa | 21 | 25% rutile and 75% anatase | NA | Sonicated for 10–15 min | 200 | 24 h | HaCaT | MEM | NAC, UVA/NAC: 5 mM, 2 h UVA: 365 nm, 3.5 W/cm2, 1 h | Cell viability (UVA)↓ (UVA + NAC)↑, LDH (UvA+NAC)↓, apoptosis assay (UVA + NAC)↓, ROS (UVA + NAC)↓, MMP (UVA + NAC)↑, K6 mRNA (UVA + NAC)↑ |
| 75 | Sigma-Aldrich | NA | anatase and rutile | NA | Sonicated for 30 min | 200 | 12 h | U87-MG | DMEM | UVA/365 nm, 5 J/cm2, 20 min | Cell viability↓, BCL2↓, BAX↑ |
| 82 | Degussa | NA | NA | NA | NA | 61, 60 | 10 min | Leukemia K562 | RPMI-1640 | Daunorubicin, UVA/daunorubicin: 0.14 mM, 0.2 mM UVA: 100 s | Drug accumulation↑ |
Abbreviations: ↑ combined effect showed a significant increase than TiO2 NPs group and other factor group alone; ↓ combined effect showed a significant decrease than TiO2 NPs group and other factor group alone; ↔, combined effect showed no significant difference than TiO2 NPs group and other factor group alone; 8-OHdG, 8-hydroxydeoxyguanosine; GSH, glutathione; HO-1 gene, heme oxygenase 1 gene; MMP, mitochondrial membrane potential; NA, data not available; NPs, nanoparticles; OGG1, 8-oxoguanine DNA glycosylase homologue 1; ROS, reactive oxygen species; SOD, superoxide dismutase; TiO2, titanium dioxide; UVA, ultraviolet A ; DNA, deoxyriboNucleic acid; MDA, malondialdehyde; CAT, catalase activities; NO, nitric oxide; PARP, poly (ADP-ribose) polymerase ; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; NAC, N-acetyl cysteine; LDH, lactic acid dehydrogenase; mRNA, messenger ribonucleic acid; BAX, Bcl-2-associated X protein; DMEM, Dulbecco’s Modified Eagle’s Medium; TU, toxic unit; MEM, Minimum Essential Medium; ADP, adenosine diphosphate; min, minutes; PbAC, Plumbi Acetatis; BPA, bisphenol A; HBE, human bronchial epithelial cell; NaF, sodium fluoride; h, hours; HaCaT, a cell type belonging to an immortal human keratinocyte line; RPMI, Roswell Park Memorial Institute; BCL2, B-cell lymphoma 2 protein.
Figure 2Interactive effects (degradation and absorption) of titanium dioxide (TiO2) nanoparticles (NPs) with chemicals under ultraviolet A (UVA) radiation.
Abbreviations: OH, hydroxyl radicals; O2, oxygen; O2–, superoxide radical; H2O, water; e−, electron; h+, the positive hole.
Studies in vivo on the interactive effects of TiO2 NPs with chemicals or physical factors
| Reference | Supplier | Characteristics of TiO2 NP
| Dispersion method | Living organism | Exposure concentration | Exposure method | Exposure time | Exposure condition of combined factors and experiment | Combined effects | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Particle size (nm) | Crystal structure | Surface area (m2/g) | |||||||||
| 20 | Zhejiang Hongsheng Nanotechnology | 50, 120 | NA | NA | Sonicated for 20 min | Kun Ming mice | 5 g/kg | Oral gavage | 7 d | PbAC: 500 mg/kg | Liver and kidney function↓; ROS: liver↑, kidney/cortex/hippocampus↔; MDA↔; liver/kidney: SOD↔, GSH-Px↔, cortex and hippocampus: SOD↓, GSH-Px↓ |
| 32 | Skyspring Nanomaterials Inc | 5–10 | NA | NA | Mixed in a shaker for 24 h | 200 mg/L | In food | 24 h | NaH2 AsO4 : 0, 0.45, 0.75, 1.5, 2.25, 2.5, 3, and 4.5 mg/L; pH = 7.8, T = 20°C | TiO2 NPs concentration: mortality at low dose↑; mortality at high dose↓ | |
| 35 | Nanjing High Technology Material | 13.5 | Anatase | NA | Sonicated for at least 30 min | 2 mg/L | In water | 3 d | Copper nitrate: 10, 20, 30, 40, 50, 70 and 100 μg/L; pH = 7.6, T = 23°C | Cu2+ LC50↓, metallothionein level↓ | |
| 41 | Degussa | 21 | NA | 50 | NA | 10.0 ± 1.3 mg/L | In water | 0, 5, 10, 15, 20, 25 d | Cd: 3 4.4 ± 4.8 μg/l, 97.3 ± 6.9 μg/L; pH = 7.8, T = 23°C ± 2°C | Cd accumulation↑ | |
| 42 | Evonik Degussa | 21 | NA | 50 ± 15 | Pre-equilibrated for at least 24 h | Zebrafish | 5, 10, 20 mg/L | In water | 0, 1, 2, 5, 8, 12, 16, 20 d | HA: 5, 10, 20 mg/L; Cd: 50 μg/L; pH = 7.0, T = 25°C ± 2°C | Uptake rate constants of Cd bioaccumulation: HA/TiO2↑, HA & TiO2↓ |
| 43 | vivo Nano | 1–10 | Anatase | NA | Coated with hydrophilic sodium polyacrylate | 1, 3, 10, 30, and 100 mg/L | In water | 0, 0.25, 0.5, 0.75, 1, 2, 6 h | Cd: 0, 0.1, 0.3, 0.5, 0.8, 1.0, and 3.0 mg/L; pH = 7.5 ± 0.1, T = 25°C | Free Cd2+ concentration in media↓ | |
| 58 | Degussa | 21 | NA | NA | Ultrasonicated for 10 min | 0, 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50, 60, 80, and 100 mg/L | In water | 10 min | Lysozymes: 0, 0.42, 0.97, 1.39, 2.08 μM; pH = 7.4 | Bacteriolysis activity of lysozyme↓ | |
| 69 | Alfa Aesar | 5, 10, 32 | NA | 210, 115, 45 | NA | 31, 1, 3.1, 10, 31, 100, 310, and 1000 mg/L | In water | 14 d | UVA: 400 mW/m2; pH = 7.0~7.8 | ||
| 75 | Sigma-Aldrich | NA | Anatase and rutile | NA | Sonicated for 30 min | Female BALB/c nude mice | 200 μg per tumor | Air pouch | 12 h | UVA: 365 nm, 5 J/cm2, 30 min | Necrosis↑, apoptosis↑, tumor growth↓, survival↑ |
| 79 | Degussa | 21 | 80% anatase, 20% rutile | 50 ± 15 | Sonicated for 10 min | 0.02, 0.2, and 2.0 mg/L | In water | 72 h | Pirimicarb: 20 μg/L; UVA: 300–400 nm, 40 ± 5 W/m2, 15 min; T = 20°C ± 1 °C | UVA and nTiO2: pirimicard concentration↓ | |
| 80 | Degussa | 27 | NA | 50 | Dispersed on 5 A or 13X surface | 1, 5, 10, and 15 wt% | In solution | 30, 60, 270 min | OTC: 50 mg/L; UVA: 254 nm, 845 μW/cm2, 2 h; pH = 7 | (TiO2/5A or TiO2/13X) and UVA: inhibition rate↑ | |
Note:
The combined effects are effects with TiO2 NPs and combined factors, comparing with effects of nTiO2 or combined factor alone.
Abbreviations: ↓, inhibit, decrease, suppress, or delay; ↑, increase; ↔, no significant changes; GSH, glutathione; NA, data not available; NPs, nanoparticles; ROS, reactive oxygen species; SOD, superoxide dismutase; T, temperature; TiO2, titanium dioxide; UVA, ultraviolet A; MDA, malondialdehyde; CD, cadmium; HA, humic acid; NaH2 AsO4, sodiumarsenate; OTC, oxytetracycline; min, minutes; PbAC, Plumbi Acetatis; h, hours; d, days; pH, the acidity or basicity of an aqueous solution; nTiO2, nano-TiO2.